elmustine has been researched along with Benign Supratentorial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiras, J; Delattre, JY; Fauchon, F; Poisson, M | 1 |
| Brotchi, J; Chatel, M; Gédouin, D; Georges, P; Hildebrand, J; Przedborski, S | 1 |
1 review(s) available for elmustine and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
[Treatment of supratentorial glioma in adults by intra-arterial HECNU. Experience of the Pitié-Salpétrière group].
Topics: Glioma; Humans; Injections, Intra-Arterial; Mutagens; Nitrosourea Compounds; Prognosis; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Analysis | 1992 |
1 trial(s) available for elmustine and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Effect of HECNU in malignant supratentorial gliomas--a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Female; Glioma; Humans; Male; Middle Aged; Nitrosourea Compounds; Supratentorial Neoplasms | 1988 |